Data protection Impressum

Biotech

Alithea Genomics, which emerged from the EPFL in 2020, has distinguished itself within the life sciences sector with its cutting-edge RNA sequencing solutions.

Alithea Genomics embarks on next-phase growth with CHF 2.8 million funding

18 March 2024

Top Stories Western Switzerland

Top Stories from Western Switzerland (February 2024)

27 February 2024

This significant financial backing underscores the potential of Alys's comprehensive pipeline targeting a broad spectrum of dermatological indications, from atopic dermatitis to psoriasis.

Alys Pharmaceuticals launches in Geneva with USD 100 million investment

19 February 2024

The breakthrough comes from the University's Autophagy Laboratory, where Prof. Patricia Boya and her team, in collaboration with the Spanish Margarita Salas Center for Biological Research (CIB-CSIC), have demonstrated the potential of specific drugs to stimulate mitophagy, thereby enhancing the ability of cells to "clean house" even as they age.

University of Fribourg discovers drug to combat age-related neuroinflammation

12 February 2024

GeNeuro‘s mission is to leverage HERV biology to develop safe and effective treatments for the benefit of patients, by neutralizing causal factors encoded by HERVs that represent 8% of human DNA.

GeNeuro secures EUR 5 million to advance post-COVID and neurodegenerative disease treatments

5 February 2024

In 2023, Swiss start-ups faced a challenging investment climate, marked by a significant reduction in venture capital funding.

Business environment

Swiss start-ups raised CHF 2.6 billion in 2023

30 January 2024

Top Stories Western Switzerland

Top Stories from Western Switzerland (January 2024)

30 January 2024

Onward Therapeutics’ move marks a critical transition for the company into the clinical stage, solidifying its role in developing innovative cancer treatments.

Onward Therapeutics enters clinical phase with innovative cancer immunotherapy

30 January 2024

This CHF 18 million initiative focuses on developing artificial intelligence-guided neuromodulation therapies to treat neurologic and mental health disorders.

Wyss Center launches Lighthouse Partnership with key institutions from Western Switzerland

29 January 2024

Founded in 2016 in Argentina, Stämm, now boasting a robust team of over 200 in Buenos Aires and San Francisco, specializes in harnessing nature-inspired, data-driven solutions to revolutionize bioprocessing.

Biomanufacturing innovator Stämm opens its European R&D facility in Monthey

25 January 2024

1 … 8 9 10 11 12 13 14 15 16 … 24